Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

87
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

7.4K
Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
7.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A direct interaction of JAM-C with the tight junction scaffold protein ZO-2.

Scientific reports·2026
Same author

Uncovering the electrical synapse proteome in retinal neurons via in vivo proximity labeling.

eLife·2026
Same author

Junctional adhesion molecule-C: A multifunctional mediator of cell adhesion.

Cellular and molecular life sciences : CMLS·2025
Same author

Uncovering the electrical synapse proteome in retinal neurons via in vivo proximity labeling.

bioRxiv : the preprint server for biology·2024
Same author

Functional multi-organelle units control inflammatory lipid metabolism of macrophages.

Nature cell biology·2024
Same author

PALS1 is a key regulator of the lateral distribution of tight junction proteins in renal epithelial cells.

Journal of cell science·2024

Related Experiment Video

Updated: Sep 13, 2025

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.2K

JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis.

Mariel F Schwietzer1, Klaus Ebnet2

  • 1Molecular Cardiology, Cardiology I, Medical Clinic C, University Hospital Münster, 48419, Münster, Germany.

Current Atherosclerosis Reports
|July 29, 2025
PubMed
Summary

Junctional Adhesion Molecule-A (JAM-A) is crucial in atherosclerosis development. Its redistribution on endothelial cells and release from platelets promote inflammation, thrombus formation, and disease progression.

Keywords:
AtherosclerosisCoronary artery diseaseJAM-ALeukocyte-endothelial cell interactionPlatelet aggregationThrombosis

More Related Videos

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

7.7K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.2K
Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

7.7K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.3K

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Adhesion

Background:

  • Cell-cell adhesion is vital in vascular inflammation and thrombus formation.
  • Junctional Adhesion Molecule-A (JAM-A), an immunoglobulin superfamily receptor, mediates leukocyte, platelet, and endothelial cell interactions.

Purpose of the Study:

  • To comprehensively review the role of JAM-A in atherosclerosis.
  • To elucidate the mechanisms by which JAM-A contributes to atherogenesis.

Main Methods:

  • Review of existing literature on JAM-A function in vascular biology.
  • Analysis of JAM-A expression and localization in response to inflammatory stimuli.
  • Investigation of soluble JAM-A (sJAM-A) in platelet function and aggregation.

Main Results:

  • Proinflammatory stimuli redistribute JAM-A on endothelial cells, enhancing monocyte adhesion and transmigration.
  • Platelet activation increases surface JAM-A and releases sJAM-A, promoting platelet aggregation and thrombus formation.
  • Elevated sJAM-A levels correlate with recurrent myocardial infarction, highlighting its clinical relevance.

Conclusions:

  • JAM-A is a key mediator in atherogenesis, influencing endothelial cell activation, platelet function, and leukocyte recruitment.
  • Understanding JAM-A's mechanisms offers potential therapeutic targets for atherosclerosis and related cardiovascular diseases.